Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.
Key Details
- 1Vara's breast triage tool received CE Certification under EU Medical Device Regulation.
- 2The AI autonomously flags normal screening mammograms; others are read by at least one radiologist.
- 3Designed to support organized population screening, especially in areas facing radiologist shortages.
- 4Atmon system continually monitors performance and can revert to full radiologist review if quality signals deteriorate.
- 5The approval aligns with new EU AI Act requirements for high-risk systems to have human oversight.
Why It Matters
This marks a breakthrough in AI autonomy for radiology, potentially alleviating radiologist workload and addressing workforce shortages in breast screening. The built-in safety mechanisms and regulatory oversight set a precedent for broader AI adoption and governance in imaging.
Source
Radiology Business
Related News
•Radiology Business
Elucid Secures $55M Series D to Expand AI Cardiovascular Imaging
Elucid raises $55M Series D to advance its AI software for cardiovascular CT analysis.
•Radiology Business
Medicare Grants Add-On Payment for Aidoc's AI CT Body Triage Tool
Medicare has approved new inpatient add-on payments for Aidoc's AI-powered CT Body Triage tool, supporting hospitals' adoption of this technology.
•AuntMinnie
Deep Learning on DBT Enhances Five-Year Breast Cancer Risk Prediction
A longitudinal DBT-based deep learning model outperformed conventional mammography and clinical models for five-year breast cancer risk prediction.